Downregulation of innate and acquired antitumor immunity by bystander γδ and αβ T lymphocytes with Th2 or Tr1 cytokine profiles

Journal of Interferon and Cytokine Research

Volumn 19, Issue 6, 1999, Pages 555-561

  Seo, Naohiro ^a   Tokura, Yoshiki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HELPER CELL; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY;

ANIMALS; CYTOKINES; DOWN-REGULATION; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MELANOMA, EXPERIMENTAL; MICE; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TH2 CELLS;

ANIMALIA; MURINAE;

EID: 0032811003     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313686     Document Type: Review

References (66)

1. KAUFMANN, S.H.K. (1995). Immunity to intracellular microbial pathogens. Immunol. Today 16, 338-342.
2. GARSIDE, P., and MOWAT, A.M. (1995). Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defence? Immunol. Today 16, 220-223.
3. TRINCHIERI, G. (1995). Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adoptive immunity and of hematopoiesis. Sem. Immunol. 7, 83-88.
4. + T cells upon NKR-P1 cross-linking, J. Exp. Med. 183, 2391-2396.
5. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-577.
6. BOEHM, U., KLAMP, T., GROOT, M., and HOWARD, J.C. (1997). Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15, 749-795.
7. BEZOUSKA, K., YUEN, C.-T., O'BRIEN, J., CHILDS, R.A., CHAI, W., LAWSON, A.M., DRBAL, K., FISEROVA, A., POSPISIL, M., and FEIZI, T. (1994). Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 372, 150-157.
8. YOKOYAMA, W.M., and SEAMAN, W.E. (1993). The Ly-49 and NKR-P1 gene families encoding lectin like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11, 613-635.
9. KARLHOFER, F.M., and YOKOYAMA, W.M. (1991). Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2 activated NK cells possess additional specific stimulation pathways. J. Immunol. 146, 3662-2673.
10. RYAN, J.C., NIEMI, E.C., NAKAMURA, M.C., and SEAMAN, W.E. (1995). NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J. Exp. Med. 181, 1911-1915.
11. BRENNAN, J., MAGER, D., JEFFERIES, W., and TAKEI, F. (1994). Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180, 2287-2295.
12. WANG, L.L., MEHTA, I.K., LEBLANC, P.A., and YOKOYAMA, W.M. (1997). Mouse natural killer cells express gp48B1, a structural homologue of human killer inhibitory receptors. J. Immunol. 158, 13-17.
13. YU, Y.Y., GEORGE, T., DORFMAN, J.R., ROLAND, J., KUMAR, V., and BENNETT, M. (1996). The role of Ly-49A and 5E6 (Ly-49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 4, 67-76.
14. KANE, K.P. (1994). Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J. Exp. Med. 179, 1011-1015.
15. PERUZZI, M., WAGTMANN, N., and LONG, E.O. (1996). A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 184, 1585-1590.
16. RAJAGOPALAN, S., and LONG, E.O. (1997). The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185, 1523-1528.
17. TRINCHIERI, G. (1994). Recognition of major histocompatibility complex class I antigens by natural killer cells. J. Exp. Med. 180, 417-121.
18. b in RMA-S cells does not affect alloreactive T cell- and natural killer cell-mediated lysis. Immunol. Lett. 38, 77-83.
19. b) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells. Eur. J. Immunol. 20, 841-846.
20. McMILLAN, T.J., RAO, J., EVERETT, C.A., and HART, I.R. (1987). Interferon-induced alterations in metastatic capacity, class I antigen expression and natural killer cell sensitivity of melanoma cells. Int. J. Cancer 40, 659-666.
21. CORREA, I., and RAULET, D.H. (1995). Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2, 61-71.
22. HOLSCHER, M., GIVAN, A.L., and BROOKS, C.G. (1991). The effect of transfected MHC class I genes on sensitivity to natural killer cells. Immunology 73, 44-51.
23. MALNATI, M.S., PERUZZI, M., PARKER, K.C., BIDDISON, W.E., CICCONE, E., MORETTA, A., and LONG, E.O. (1995). Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267, 1016-1019.
24. MOSMANN, T.R., and COFFMAN, R.L. (1989). TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
25. NAGLER, A., LANIER, L.L., and PHILLIPS, J.H. (1988). The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J. Immunol. 141, 2349-2358.
26. SPITS, H., YSSEL, H., PALIARD, X., KASTELEIN, R., FIGDOR, C., and DE VRIES, J.E. (1998). IL-4 inhibits IL-2-mediated induction of human lymphocyte-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte culture. J. Immunol. 141, 29-36.
27. HUMPHREYS, T., and REINHERZ, E.L. (1994). Invertebrate immune recognition, natural immunity and the evolution of positive selection. Immunol. Today 15, 316-320.
28. STORKUS, W.J., SALTER, R.D., CRESSWELL, P., and DAWSON, J.R. (1992). Peptide-induced modulation of target cell sensitivity to natural killing. J. Immunol. 149, 1185-1190.
29. + cells. J. Immunol. 160, 1158-1165.
30. + thymocyte population associated with intact Fas antigen expression on the target. J. Exp. Med. 180, 423-432.
31. + natural T cells. Int. J. Cancer 70, 450-460.
32. BLUMBERG, R.S., TERHORST, C., BLEICHER, P., McDERMOTT, F.V., ALLAN, C.H., LANDAU, S.B., TRIER, J.S., and BALK, S.P. (1991). Expression of a nonpolymorphic MHC class I-Iike molecule, CD1D, by human intestinal epithelial cells. J. Immunol. 147, 2518-2524.
33. + T lymphocytes. Science 268, 863-867.
34. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179, 1285-1295.
35. KELSALL, B.L., STUBER, E., NEURATH, M., and STROBER, W. (1996). Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann. NY Acad. Sci. 795, 116-124.
36. SEAMAN, W.E., SLEISENGER, M., ERIKSSON, E., and KOO, G.C. (1987). Depletion of natural killer cells in mice by monoclonal antibody to NK1.1. Reduction in host defence against malignancy without loss of cellular or humoral immunity. J. Immunol. 138, 4539-1548.
37. int liver lymphocytes: influence of thymus. β2-microglobulin and NK1.1 expression. Int. Immunol. 7, 1729-1739.
38. + NK T lymphocytes. J. Immunol. 161, 3271-3281.
39. YAMADA, H., NINOMIYA, T., HASHIMOTO, A., TAMADA, K., TAKIMOTO, H., and NOMOTO, K. (1998). Positive selection of extrathymically developed T cells by self-antigens. J. Exp. Med. 188, 779-784.
40. + cytotoxic T cells can be generated by IL-2 exposure from lymphocytes which express an intermediate level of T cell receptor. Immunol. Lett. 61, 165-173.
41. SATO, K., OHTSUKA, K., HASEGAWA, K., YAMAGIWA, S., WATANABE, H., ASAKURA, H., and ABO, T. (1995). Evidence for extrathemic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J. Exp. Med. 182, 759-768.
42. - TCR αβ intermediate T cells in the liver of normal adult mice: implication for lpr pathogenesis. Int. Immunol. 6, 533-540.
43. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol. 154, 4333-4340.
44. b molecules expressed on Th2-type γδ T and αβ T cells co-infiltrating in early B16 melanoma lesions. J. Immunol. 161, 4138-4145.
45. LIBERO, G.D. (1997). Sentinel function of broadly reactive human γδ T cells. Immunol. Today 18, 22-26.
46. KOWALCZYK, D., SKORUPSKI, W., KWIAS, Z., and NOWAK, J. (1996). Activated γδ T lymphocytes infiltrating renal cell carcinoma. Immunol. Lett. 53, 15-18.
47. + T cells. Immunology 81, 27-35.
48. KAMINSKI, M.J., CRUZ, P.D., BERGSTRESSER, P.R., JR., and TAKASHIMA, A. (1993). Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. Cancer Res, 53, 4014-4019.
49. + T cell development in CD3ζ-deficient mice. J. Exp. Med. 182, 891-895.
50. WEN, L., BARBER, D.F., PAO, W., WONG, F.S., OWEN, M.J., and MAYDAY, A. (1998). Primary γδ cell clones can be defined phenotypically and functionally as Th1/Th2 cells and illustrate the association of CD4 with Th2 differentiation. J. Immunol. 160, 1965-1974.
51. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742.
52. OKAMURA, H., KASHIWAMURA, S., TSUTSUI, H., YOSHIMOTO, T., and NAKANISHI, K. (1998). Regulation of interferon-gamma production by IL-12 and IL-18. Cur. Opin. Immunol. 10, 259-264.
53. MICALLEF, M.J., TANIMOTO, T., KOHNO, K., IKEDA, M., and KURIMOTO, M. (1997). Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res. 57, 4557-4563.
54. CUA, D.J., and STOHLMAN, S.A. (1997). In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets. J. Immunol. 159, 5834-5840.
55. BLOOM, B.M., PERRY-LALLEY, D., ROBBINS, P.F., LI, Y., EL-GAMIL, M., ROSENBERG, S.A., and YANG, J.C. (1997). Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J. Exp. Med. 185, 453-459.
56. SEO, N., and EGAWA, K. (1995). Suppression of cytotoxic T lymphocyte activity by γ/δ T cells in tumor-bearing mice. Cancer Immunol. Immunother. 40, 358-366.
57. SEO, N., TOKURA, Y., TAKIGAWA, M., and EGAWA, K. (1999). Depletion of IL-10-and TGF-β-producing regulatory γδ T cells by administering a dounomycin-conjugated specific mAb in early tumor lesions augments the activity of CTLs and NK cells. J. Immunol. In press.
58. BOHM, W., THOMA, S., LEITHAUSER, F., MOLLER, P., SCHIRMBECK, R., and REIMANN, J. (1998). T cell-mediated. IFN-γ-facilitated rejection of murine B16 melanomas. J. Immunol. 161, 897-908.
59. + NK T cells. J. Immunol. 158, 2976-2082.
60. KANTO, T., TAKEHARA, T., KATAYAMA, K., ITO, A., MOCHIZUKI, K., KUZUSHITA, N., TATSUMI, T., SASAKI, Y., KASAHARA, A., HAYASHI, N., and HORI, M. (1997). Neutralization of transforming growth factor β1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro. J. Clin. Immunol. 17, 462-471.
61. MAEDA, H., and SHIRAISHI, A. (1996). TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 156, 73-78.
62. ZHENG, L.M., OJCIUS, D.M., GARAUD, F., ROTH, C., MAXWELL, E., LI, Z., RONG, H., CHEN, J., WANG, X.Y., CATINO, J.J., and KING, I. (1996). Interleukin-10 inhibits tumor metastasis through an NK cell-mediated mechanism. J. Exp. Med. 184, 579-584.
63. WANG, L., GOILLOT, E., and TEPPER, R.I. (1994). IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell. Immunol. 159, 152-169.
64. + T cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 159, 97-106.
65. + cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158, 5112-5120.
66. + T cells. J. Exp. Med. 186, 1407-1418.